Upwork (UPWK) +38.37% Had IPO today, surged at debut.
Novavax (NVAX) +12.10% Upgraded from "Sell" rating to "Hold" by BidaskClub, setting a $2.00 price target.
Cymabay Therapeutics (CBAY) +9.91% Announced positive results from Phase II study of Seladelpar, a drug for Primary Biliary Cholangitis.
Radius Health (RDUS) +9.70% Announced 2019 Medicare Part D Coverage for RDUS's Tymlos injection.
Iovance Biotherapeutics (IOVA) +9.83% Chardan Capital reiterated a "Buy" rating on IOVA, set a price target at $30.
Fossil (FOSL) +7.65% Announced partnership with Citizen to create hybrid smartwatches.
Intelsat (I) +6.58% Cowen stated that Intelsat could reap "$5 billion or more" in the upcoming 5G market.
Assembly Biosciences (ASMB) -7.20% Equity lockup period expires on October 10 and sentiment is negative.
Kiniska Pharmaceuticals (KNSA) -5.50% Non-deal roadshow in Chicago fails to impress investors.
Ring Energy (REI) -4.59% Third quarter operations update creates negative outlook for investors.
RPM International (RPM) -4.24% Missed first quarter EPS expectations. EPS was $0.76 versus the $0.86 expectation.
Veoneer (VNE) -3.62% UBS downgrades from "Neutral" to "Sell" rating, stating the stock is seeing "over-optimism" on sales and profit.
Sturm, Ruger & Co. (RGR) -3.40% Gun stocks drop on negative background-check data for September.